GSK set for high in­vest­ment

Enterprise - - News -

The direc­tion of Glax­oSmithK­line’s high in­vest­ment is now fo­cused on Pak­istan, as stated by GSK’s Fi­nance Di­rec­tor Con­sumer Health­care Mid­dle East re­gion, Paul Mar­son, at the re-launch cer­e­mony of Sen­so­dyne tooth­paste. GSK is look­ing to­wards ag­gres­sive in­vest­ments in de­vel­op­ing health­care prod­ucts in Pak­istan. The com­pany has an­nounced the in­jec­tion of Rs. 2 bil­lion for the ini­tial in­vest­ment phase. GSK be­lieves Pak­istan is a lu­cra­tive in­vest­ment des­ti­na­tion and ex­pects prof­itable rev­enues for the com­pany through new ex­pan­sion.

Sen­so­dyne is a prod­uct for sen­si­tive teeth, which now on­wards will be mar­keted to con­sumers di­rectly in­stead of be­ing pro­moted with den­tists only. It is GSK’s aim to gen­er­ate em­ploy­ment op­por­tu­ni­ties for the lo­cal pop­u­la­tion through heavy in­vest­ments

Newspapers in English

Newspapers from Pakistan

© PressReader. All rights reserved.